Prof. Sir Tony Kouzarides Tony is Professor of Cancer Biology at the University of Cambridge, a group leader at the Gurdon Institute and a director/founder of the Milner Therapeutics Institute. He did his PhD at the University of Cambridge and postdoctoral work at the Cambridge MRC Laboratory of Molecular Biology and at New York University Medical Centre. His lab at the Gurdon Institute studies epigenetic modifications of histones and RNA. He is co-founder and CEO of Vellos, Venture Partner at Fifty Years, co-founder and director of Storm Therapeutics, co-founder of Abcam plc and co-founder of Chroma Therapeutics.